Probiotics for dogs and cats have moved from fringe supplement to mainstream adjunct therapy in the last decade. The evidence base has grown. The quality of the commercial products has improved. The conditions where probiotics are most useful have been better defined. And the placebo response rate — both in the pet and in the owner — has been more honestly acknowledged. This article is the practical view from the dermatologist's chair, written for the owner who is considering probiotics for a pet with skin disease and wants to know what is real and what is marketing.
We will go through the gut-skin axis, the strains that have evidence, the dosing, the products that work, the products that don't, the conditions where probiotics are most useful, the conditions where they are not, and the four mistakes that lead to wasted money or false expectations.
The gut-skin axis
The concept of a "gut-skin axis" has been studied extensively in both human and veterinary medicine. The basic idea: the gut microbiome (the population of bacteria, yeast, and other microorganisms in the intestinal tract) has systemic effects on immune function, inflammation, and skin health. Disruption of the gut microbiome (dysbiosis) is associated with a wide range of inflammatory conditions, including skin disease.
The mechanisms are not fully understood but include:
- Immune system education in the gut. The gut-associated lymphoid tissue (GALT) is the largest immune organ in the body. The gut microbiome interacts with the GALT and shapes the systemic immune response. An imbalanced microbiome can produce a pro-inflammatory immune state that manifests in the skin.
- Short-chain fatty acid production. Gut bacteria ferment dietary fibre and produce short-chain fatty acids (SCFAs) like butyrate, propionate, and acetate. SCFAs have systemic anti-inflammatory effects, including effects on skin inflammation.
- Bile acid metabolism. Gut bacteria modify primary bile acids into secondary bile acids, which have systemic effects on metabolism and inflammation.
- Tryptophan metabolism. Gut bacteria metabolise tryptophan into various indole derivatives that affect immune function through the aryl hydrocarbon receptor.
- Direct competition with pathogens. A healthy gut microbiome competes with pathogenic bacteria for resources and binding sites, reducing the risk of intestinal overgrowth and systemic inflammation.
Disruption of any of these mechanisms can contribute to inflammatory skin disease. Restoration of the gut microbiome, through probiotics, prebiotics, or faecal microbiota transplantation, can theoretically improve skin health. The evidence for this in dogs and cats is growing but is still limited to specific conditions and specific strains.
The strains with evidence
Not all probiotics are the same. The strain matters. A probiotic is defined by its genus, species, and strain designation. For example, "Lactobacillus rhamnosus GG" is a specific strain with specific properties. A different strain of L. rhamnosus may have different properties. The evidence for one strain does not generalise to all strains of the same species, let alone to all probiotics.
The strains that have the most evidence in canine and feline skin disease:
Lactobacillus rhamnosus GG (LGG). The most studied probiotic strain in veterinary dermatology. Multiple studies in dogs with atopic dermatitis have shown improvements in clinical scores, reductions in pruritus (itching), and reductions in the use of anti-inflammatory medications. The mechanism is thought to involve modulation of the Th1/Th2 immune balance, shifting the immune response away from the IgE-mediated allergic pattern. Dose: typically 10^10 CFU (10 billion colony-forming units) per day for medium to large dogs.
Bifidobacterium animalis AHC7. Another well-studied strain in dogs. A 2008 study in dogs with atopic dermatitis showed significant improvements in clinical scores and reductions in pruritus. The strain has been incorporated into several commercial veterinary probiotic products. Dose: 10^9 to 10^10 CFU per day.
Lactobacillus paracasei K71. Studied in dogs with atopic dermatitis, with some evidence of clinical improvement. Less extensively studied than LGG or B. animalis AHC7.
Enterococcus faecium SF68. Studied primarily in dogs with gastrointestinal disease (diarrhoea), with some evidence of immune-modulating effects that may benefit skin disease. Less directly studied for skin disease than LGG.
Lactobacillus reuteri. Multiple strains studied in both humans and animals for various conditions, including some skin conditions. The evidence in dogs and cats for skin disease is less robust than for LGG.
Multi-strain products. Several commercial products contain multiple strains (Lactobacillus, Bifidobacterium, Enterococcus). The combination may provide broader benefits, but the evidence for any specific multi-strain combination in skin disease is less robust than for the single-strain products above.
The honest summary: LGG and B. animalis AHC7 have the best evidence for skin disease in dogs. Other strains may have benefits, but the evidence is less clear.
The dosing
The dosing for probiotics is not as standardised as for pharmaceutical drugs. The CFU count on the label is the starting point, but the actual dose that reaches the gut depends on the product formulation, the storage conditions, and the survival of the organisms through the stomach acid.
General guidelines for dogs:
- Small dogs (under 10 kg): 10^9 to 10^10 CFU per day
- Medium dogs (10 to 25 kg): 10^10 CFU per day
- Large dogs (over 25 kg): 10^10 to 10^11 CFU per day
For cats: 10^9 CFU per day is typical, scaled to body size.
The dosing is usually divided into two doses per day (morning and evening with food), but once-daily dosing is also acceptable for most products.
The product should be given with food, which buffers the stomach acid and improves survival of the organisms through to the small intestine.
The duration of treatment: most studies show benefits within 4 to 8 weeks. The probiotic is typically continued long-term, as the benefits are maintained only while the probiotic is being given. Discontinuation usually results in gradual return to baseline.
The products that work
The commercial veterinary probiotics with the most evidence:
FortiFlora (Purina). Contains Enterococcus faecium SF68. The most widely used veterinary probiotic. The evidence is strong for GI indications (diarrhoea) and reasonable for immune modulation. Less evidence specifically for skin disease than LGG or B. animalis AHC7. The product is in a palatable powder form that can be sprinkled on food.
Proviable (Nutramax). Contains multiple strains including Bifidobacterium and Lactobacillus. Multi-strain product with reasonable evidence for GI support and some evidence for skin benefits.
Visbiome Vet (Exegi). A high-potency multi-strain probiotic that has been used in veterinary medicine. Originally a human product. Strong formulation with multiple strains. The evidence in dogs for skin disease is less established than for LGG or B. animalis AHC7 specifically, but the product is well-formulated.
Culturelle (i-Health). The human product containing Lactobacillus rhamnosus GG. Widely available. Many veterinarians recommend the human product for dogs because it is the LGG strain with the most evidence. The dose needs to be scaled to the dog's body weight.
Generic Lactobacillus rhamnosus GG. Available from various supplement manufacturers. The strain is the same as in Culturelle, but the formulation and the quality control vary. The owner who buys a generic LGG product should verify the CFU count and the expiry date.
The products that don't work:
- Most pet-store "probiotic" treats and chews. The CFU count is often too low to have a clinical effect. The strains are not always disclosed. The palatability is often prioritised over the formulation.
- Probiotics that require refrigeration and have not been refrigerated. The CFU count drops rapidly if the cold chain is broken. The owner who buys a refrigerated probiotic and leaves it on the counter has bought an expensive placebo.
- Probiotics with expired or unverified CFU counts. The label claim is not always accurate. Independent testing has shown that some commercial probiotics contain far fewer organisms than the label claims.
- "Prebiotic and probiotic" combination products where the prebiotic is the dominant ingredient. The prebiotic (typically inulin or FOS) can actually cause GI upset in some dogs and may worsen dysbiosis rather than improve it.
The conditions where probiotics are most useful
Canine atopic dermatitis. The most evidence-supported indication. Multiple studies show clinical improvement when LGG or B. animalis AHC7 is added to the standard management (allergen avoidance, topical therapy, anti-inflammatory medication). The improvement is moderate — typically 20 to 30% reduction in clinical scores — and the probiotic is an adjunct, not a replacement for the standard therapies.
Flea allergy dermatitis (as adjunct to flea control). Some evidence that probiotics reduce the inflammatory response to flea bites in sensitised dogs, but the primary management is strict flea control. The probiotic is an adjunct, not a substitute.
Food allergy (as adjunct to diet trial). Some evidence that probiotics reduce GI inflammation in dogs with food allergy, but the primary management is the strict hypoallergenic diet. The probiotic may help with the GI signs but does not address the cutaneous signs directly.
Acute diarrhoea and stress colitis. Strong evidence for probiotics in acute GI conditions, which is outside the scope of this article but worth noting because GI and skin disease often coexist in the same dog.
Chronic skin conditions in older dogs. Older dogs often have age-related dysbiosis, and probiotics may have general health benefits in addition to the skin benefits.
The conditions where probiotics are not useful
Acute allergic flare. A probiotic is not a rescue medication. An acute allergic flare needs anti-inflammatory therapy (corticosteroids, oclacitinib, lokivetmab), not a probiotic. The probiotic is for long-term management, not acute crisis.
Severe bacterial skin infection (pyoderma). The primary treatment is appropriate antibiotics (typically 3 to 4 weeks). The probiotic is an adjunct but does not replace the antibiotics.
Severe Malassezia dermatitis. The primary treatment is antifungal therapy (topical and/or systemic). The probiotic does not address the yeast overgrowth.
Mange (Sarcoptes, Demodex). The primary treatment is acaricidal therapy. The probiotic is not relevant.
Endocrine skin disease (hypothyroidism, hyperadrenocorticism). The primary treatment is hormonal management. The probiotic does not address the underlying endocrine problem.
The owner who tries to treat a serious skin condition with probiotics alone wastes time and prolongs the pet's suffering. The probiotic is an adjunct, not a primary therapy.
The four mistakes
Mistake 1: Expecting the probiotic to replace standard therapy. The owner adds a probiotic to the diet and stops the Apoquel, or stops the medicated shampoo, or stops the flea control. The skin disease flares. The probiotic alone is not sufficient for moderate to severe skin disease. The fix: continue the standard therapy. The probiotic is an addition, not a replacement.
Mistake 2: Buying a low-quality product. The owner buys the cheapest probiotic at the pet store, which has an unverified CFU count and undisclosed strains. The product has no effect. The owner concludes that probiotics don't work. The fix: buy a product with a known strain (LGG or B. animalis AHC7), a verified CFU count, and a reputable manufacturer.
Mistake 3: Giving the wrong dose. The owner gives the cat's dose to a large dog, or the small dog's dose to a cat. The dose is too low to have an effect. The fix: scale the dose to the body weight using the guidelines above.
Mistake 4: Stopping too early. The owner tries the probiotic for 2 weeks, sees no effect, and stops. The probiotic takes 4 to 8 weeks to show clinical benefit in most studies. The fix: commit to a minimum 8-week trial before evaluating the effect. If there is no improvement at 8 weeks, the probiotic is not the right one for this pet, and a different strain can be tried.
Closing the loop
Probiotics are a useful adjunct in canine and feline skin disease, particularly atopic dermatitis. The strains with the best evidence are Lactobacillus rhamnosus GG and Bifidobacterium animalis AHC7. The dose should be scaled to body weight, the product should be high-quality, and the trial should be at least 8 weeks. The probiotic is an adjunct to the standard therapy, not a replacement for it. The owner who understands the evidence, who uses a quality product at the right dose for the right duration, and who continues the standard therapy, will likely see some benefit. The owner who expects a miracle, who buys the cheapest product, who gives the wrong dose, or who stops too early, will not.
